Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medisys Technologies, Inc. was a medical technology company primarily focused on the development and commercialization of safety medical products designed to prevent accidental needle-stick injuries. The company's core product line included safety syringes and safety needles, which featured proprietary mechanisms to retract or shield the needle after use. Historically traded on the OTC market under the symbol MEDY, the company aimed to address the growing demand for healthcare worker safety in clinical settings. While it achieved commercial status with its safety device portfolio, the company is currently inactive and no longer maintains significant operations in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medisys Technologies.